Table 1 Summary of results of initial treatment (n = 35 with initial RP and n = 10 with initial RT, summary n = 45)
Total number of evaluated patients | 45 | 100 % |
|---|---|---|
Initial RT (%) | 10 | 22.2 % |
Initial RP without LND (%) | 13 | 28.9 % |
Initial RP with LND (%) | 22 | 48.9 % |
Average number of removed LN´s (n = 22) | 13.3 | 3-26 |
Average number of N1 (%) | 5 | 22.7 % |
Mean iPSA, ng/ml (SD) | 6.7 | ±1.6 |
Risk classificationa | ||
Low (%) | 1 | 2.2 % |
Intermediate (%) | 21 | 46.7 % |
High (%) | 21 | 46.7 % |
T stage after RP | ||
T2 (%) | 15 | 33.3 % |
T3 (%) | 27 | 60.0 % |
T3a (%) | 12 | 26.7 % |
T3b (%) | 15 | 33.3 % |
Tx (%) | 3 | 6.7 % |
Gleason Score after RPGS 6 (%) | ||
GS 7 (%) | 4 | 8.9 % |
GS 8 (%) | 17 | 37.8 % |
GS 9 (%) | 10 | 22.2 % |
GS 10 (%) | 10 | 22.2 % |
GSx (non detectable) (%) | 2 | 4.4 % |
2 | 4.4 % | |
R1 after initial PR (out of 35 patients) (%) | 12 | 34.3 % |